Elsevier

Journal of Critical Care

Volume 25, Issue 4, December 2010, Pages 582-590
Journal of Critical Care

Organ Failure
A pair analysis of the delayed graft function in kidney recipient: The critical role of the donor

https://doi.org/10.1016/j.jcrc.2010.02.011Get rights and content

Abstract

Purpose

The aim of this study was to analyze the importance of donor factors and especially the potential role of hemodynamic management in regard to delayed graft function in paired kidney recipient patients after renal transplantation and to analyze the urine of organ donors by proton-nuclear magnetic resonance spectroscopy to identify urine markers potentially correlated with delayed graft function in recipient patients.

Methods

A prospective multicenter epidemiologic study was conducted. A logistic regression model taking into account paired data was used.

Results

Data from 72 donors and the 144 corresponding paired recipients were analyzed. Univariate analysis showed that age of donor, previous history of tobacco, ischemic cause of brain death, norepinephrine infusion, and recipient age were the risk factors for delayed graft function. After adjusting for correlated outcome data and controlling for other potential prognostic factors, 3 variables remained significantly associated with outcome: donor age (odds ratio [OR], 10.7), hemodynamic status (OR, 0.167), and hydroxyl-ethyl starch infusion (OR, 0.135). Proton-nuclear magnetic resonance analysis evidenced 3 metabolites of interest in donors (trimethylamine-N-oxide, citrate, and lactate). However, these peaks were not correlated the clinical parameters in donors.

Conclusions

Paired analysis of kidney transplantation emphasizes the important role of factor donor associated with delayed graft function in recipient. Thus, a particular attention should be paid to the hemodynamic management of donor.

Introduction

Delayed graft function (DGF) after renal transplantation has been shown to have a significant influence on the clinical outcome after 5 years [1]. Factors associated with DGF are related to the donor, the preservation of organs, and the recipient [2]. The importance of risk factors linked to donors has been emphasized by studies reporting similar performances of paired kidneys issued from the same donor, both on short- and long-term graft function [3], [4] However, in these studies, only few donor-related factors could be identified as risk factor for DGF in recipient patients [4]. Conversely, a recent study showed that the 2 kidneys from a same donor should be considered independently regarding the DGF risk factor [5]. The evaluation of the quality of the kidneys in organ donor is based on the analysis of hemodynamic condition, plasma creatinine levels, and diuresis. The management goals regarding the hemodynamic status of the donor are to achieve normovolemia, maintain blood pressure, and optimize cardiac output with the use of the least amount of vasoactive-drug support [6]. In intensive care unit (ICU) patients, experimental and clinical data strongly suggest that vasopressor therapy is safe and probably beneficial from a renal point of view [7]. The importance of catecholamine therapy of the organ donor for the occurrence of DGF is controversial. Some authors came to the conclusion that catecholamine therapy of the donor increased the risk of DGF [8], [9]. Others showed opposite results emphasizing the importance of maintaining an efficient renal perfusion pressure with norepinephrine [10].

During acute renal failure, plasma creatinine level underestimates the level of alteration of glomerular filtration due to a potential dramatic increase of tubular creatinine secretion [11]. Inulin clearance determination, considered as the reference method, cannot be used routinely. Thus, the determination of new markers allowing a more precise assessment of the renal quality in organ donors would be of interest. Proton-nuclear magnetic resonance (1H-NMR) spectroscopy enables biologic screening with a minimal sample preparation and determines the presence of osmolites such as trimethylamine-N-oxide (TMAO) and other methylamine derivatives that have been detected in the urine after medullar ischemia [12]. However, 1H-NMR spectroscopy has not been used to assess the potential quality of organs in organ donor patients.

Thus, in this study, we sought to analyze the importance of donor factors and especially the potential role of hemodynamic management in regard to DGF amelioration in paired kidney recipient patients. Furthermore, we analyzed the urine 1H-NMR spectroscopy of organ donors to identify potential urine markers, which could be correlated to the poor quality of renal graft and predict DGF in recipient.

Section snippets

Organ donors

Patients with confirmed brain death from 4 centers were prospectively included in the study.

According to French law, confirmation of brain death requires the confirmation of brainstem function alteration (including an apnea testing) and either 2 electroencephalograms performed at 2 separated times, or injected computed tomography scan demonstrating the absence of arterial brain opacification.

Hemodynamic alteration in brain death patients was managed upon clinical assessment with the aim to

Population study

Among 120 brain-dead patients screened during the study, 25 could not have organ donation due to refusal from family [18], medical contraindication (n = 5), or unsuccessful resuscitation (n = 2). Thus, 95 patients could donate organs. Among the 95 donors, 3 patients had other than kidney organ donation, and in 4 cases, the kidneys were not grafted. Among the 88 remaining donors, only 1 kidney could be grafted in 2 cases, and in 15 cases, patients were excluded from the recipient analysis

Discussion

In this study, taking into account the paired origin of the grafts, the main 3 factors associated with DGF were donor-related. Age of donors was strongly associated with DGF. The use of high doses of norepinephrine and major fluid infusion were also independently associated with DGF. Proton-nuclear magnetic resonance analysis of urine sampled at brain death determination did not allow to clearly identify at-risk donor for recipient DGF.

Despite improvements in donor care, organ retrieval,

Acknowledgment

We thank Julie Barritault and Nadège Boildieu for her technical help.

This work has been partly supported by a Grant PHRC regional from CHU de Poitiers.

References (31)

  • LenzE.M. et al.

    Metabonomics, dietary influence and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects

    J Pharm Biomed Anal

    (2004)
  • HetzelG.R. et al.

    Risk factors for delayed graft function after renal transplantation and their significance for long-term clinical outcome

    Transpl Int

    (2002)
  • CosioF.G. et al.

    Factors related to the donor organ are major determinants of renal allograft function and survival

    Transplantation

    (1996)
  • BertoniE. et al.

    Fate of kidneys from the same donor grafted into different recipients: do they behave similarly and are they influenced by donor-related factors?

    J Nephrol

    (2000)
  • GiralM. et al.

    Effect of brain-dead donor resuscitation on delayed graft function: results of a monocentric analysis

    Transplantation

    (2007)
  • Cited by (0)

    View full text